These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25536262)

  • 1. Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.
    Kuo CF; Grainge MJ; Mallen C; Zhang W; Doherty M
    JAMA; 2014 Dec 24-31; 312(24):2684-6. PubMed ID: 25536262
    [No Abstract]   [Full Text] [Related]  

  • 2. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
    Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
    Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of gout in the real world: current practice versus guideline recommendations.
    Doghramji PP; Fermer S; Wood R; Morlock R; Baumgartner S
    Postgrad Med; 2016 Jan; 128(1):106-14. PubMed ID: 26592538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.
    Janssen CA; Jansen TLTA; Oude Voshaar MAH; Vonkeman HE; van de Laar MAFJ
    Rheumatol Int; 2017 Sep; 37(9):1435-1440. PubMed ID: 28748426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient management of gout in a New Zealand hospital: a retrospective audit.
    Kennedy NJ; Healy PJ; Harrison AA
    Int J Rheum Dis; 2016 Feb; 19(2):205-10. PubMed ID: 25873399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician adherence to ACR gout treatment guidelines: perception versus practice.
    Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
    Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
    George M; Pullman-Mooar S; Hussain F; Schumacher HR
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019.
    Jansen TL; Janssen M
    Clin Rheumatol; 2020 Jun; 39(6):2011-2016. PubMed ID: 32318971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy.
    Sultan AA; Muller S; Whittle R; Roddy E; Mallen C; Clarson L
    CMAJ; 2019 Jun; 191(22):E597-E603. PubMed ID: 31160496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Gout in a Hospital Setting: A Lost Opportunity.
    Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
    J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient related factors are also important in treating gout.
    Chandratre P; Roddy E; Mallen C
    BMJ; 2012 Jan; 344():e191. PubMed ID: 22235018
    [No Abstract]   [Full Text] [Related]  

  • 12. Adherence to urate-lowering therapy.
    Day RO
    South Med J; 2009 Jan; 102(1):114-5. PubMed ID: 19077754
    [No Abstract]   [Full Text] [Related]  

  • 13. New treatments for gout.
    Perez-Ruiz F
    Joint Bone Spine; 2007 Jul; 74(4):313-5. PubMed ID: 17606397
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database.
    Kim JW; Kwak SG; Park SH
    Korean J Intern Med; 2018 Jan; 33(1):228-229. PubMed ID: 28823114
    [No Abstract]   [Full Text] [Related]  

  • 15. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.
    Primatesta P; Plana E; Rothenbacher D
    BMC Musculoskelet Disord; 2011 May; 12():103. PubMed ID: 21599917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of gout clinic in a tertiary hospital setting.
    Leonardo N; Lester S; Whittle S; Rischmueller M
    Intern Med J; 2020 Jan; 50(1):117-120. PubMed ID: 31943621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gout in primary care: challenges and potential solutions.
    Dalbeth N
    Rheumatology (Oxford); 2013 Sep; 52(9):1549-50. PubMed ID: 23771950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gout: an overview of available urate lowering therapies].
    Richette P
    Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.
    Harrold LR; Mazor KM; Negron A; Ogarek J; Firneno C; Yood RA
    Rheumatology (Oxford); 2013 Sep; 52(9):1623-9. PubMed ID: 23620554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence with urate-lowering therapies for the treatment of gout.
    Harrold LR; Andrade SE; Briesacher BA; Raebel MA; Fouayzi H; Yood RA; Ockene IS
    Arthritis Res Ther; 2009; 11(2):R46. PubMed ID: 19327147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.